|
1
|
Cadar E, Negreanu-Pirjol T, Pascale C, Sirbu R, Prasacu I, Negreanu-Pirjol BS, Tomescu CL, Ionescu AM. Natural Bio-Compounds from Ganoderma lucidum and Their Beneficial Biological Actions for Anticancer Application: A Review. Antioxidants (Basel) 2023; 12:1907. [PMID: 38001761 PMCID: PMC10669212 DOI: 10.3390/antiox12111907] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2023] [Revised: 10/19/2023] [Accepted: 10/23/2023] [Indexed: 11/26/2023] Open
Abstract
Ganoderma lucidum (G. lucidum) has been known for many centuries in Asian countries under different names, varying depending on the country. The objective of this review is to investigate the scientific research on the natural active bio-compounds in extracts obtained from G. lucidum with significant biological actions in the treatment of cancer. This review presents the classes of bio-compounds existing in G. lucidum that have been reported over time in the main databases and have shown important biological actions in the treatment of cancer. The results highlight the fact that G. lucidum possesses important bioactive compounds such as polysaccharides, triterpenoids, sterols, proteins, nucleotides, fatty acids, vitamins, and minerals, which have been demonstrated to exhibit multiple anticancer effects, namely immunomodulatory, anti-proliferative, cytotoxic, and antioxidant action. The potential health benefits of G. lucidum are systematized based on biological actions. The findings present evidence regarding the lack of certainty about the effects of G. lucidum bio-compounds in treating different forms of cancer, which may be due to the use of different types of Ganoderma formulations, differences in the study populations, or due to drug-disease interactions. In the future, larger clinical trials are needed to clarify the potential benefits of pharmaceutical preparations of G. lucidum, standardized by the known active components in the prevention and treatment of cancer.
Collapse
Affiliation(s)
- Emin Cadar
- Faculty of Pharmacy, “Ovidius” University of Constanta, Capitan Aviator Al. Serbanescu Street, No. 6, Campus, Building C, 900470 Constanta, Romania; (E.C.); (B.-S.N.-P.)
| | - Ticuta Negreanu-Pirjol
- Faculty of Pharmacy, “Ovidius” University of Constanta, Capitan Aviator Al. Serbanescu Street, No. 6, Campus, Building C, 900470 Constanta, Romania; (E.C.); (B.-S.N.-P.)
- Academy of Romanian Scientists, Ilfov Street, No. 3, 050044 Bucharest, Romania
| | - Carolina Pascale
- Organizing Institution for Doctoral University Studies of “Carol Davila”, University of Medicine and Pharmacy of Bucharest, Dionisie Lupu Street, No. 37, Sector 2, 020021 Bucharest, Romania;
| | - Rodica Sirbu
- Organizing Institution for Doctoral University Studies of “Carol Davila”, University of Medicine and Pharmacy of Bucharest, Dionisie Lupu Street, No. 37, Sector 2, 020021 Bucharest, Romania;
| | - Irina Prasacu
- Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy of Bucharest, Traian Vuia Street, No. 6, Sector 2, 020956 Bucharest, Romania;
| | - Bogdan-Stefan Negreanu-Pirjol
- Faculty of Pharmacy, “Ovidius” University of Constanta, Capitan Aviator Al. Serbanescu Street, No. 6, Campus, Building C, 900470 Constanta, Romania; (E.C.); (B.-S.N.-P.)
| | - Cezar Laurentiu Tomescu
- Faculty of Medicine, “Ovidius” University of Constanta, University Alley, No. 1, Campus, Building B, 900470 Constanta, Romania; (C.L.T.); (A.-M.I.)
- “Sf. Ap. Andrei” County Clinical Emergency Hospital, Tomis Bvd., No. 145, 900591 Constanta, Romania
| | - Ana-Maria Ionescu
- Faculty of Medicine, “Ovidius” University of Constanta, University Alley, No. 1, Campus, Building B, 900470 Constanta, Romania; (C.L.T.); (A.-M.I.)
- Clinical Hospital C F Constanta, 1 Mai Bvd., No. 3–5, 900123 Constanta, Romania
| |
Collapse
|
|
2
|
Wu L, Zhang S, Zhou L, Xiong H, Gong X, Zhang S, Pan J, Qu H. Establishment and validation of the quantitative analysis of multi-components by single marker for the quality control of Qishen Yiqi dripping pills by high-performance liquid chromatography with charged aerosol detection. PHYTOCHEMICAL ANALYSIS : PCA 2021; 32:942-956. [PMID: 33660329 DOI: 10.1002/pca.3037] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/18/2020] [Revised: 02/02/2021] [Accepted: 02/02/2021] [Indexed: 06/12/2023]
Abstract
INTRODUCTION Charged aerosol detection (CAD) has the merits of high sensitivity, high universality and response uniformity. The strategy that combines the quantitative analysis of multi-components by single marker (QAMS) with CAD has certain advantages for the quantification of multi-components. However, relevant research was limited. OBJECTIVES To comprehensively investigate the crucial factors that affect the performance of the HPLC-CAD-QAMS approach and validate the credibility and feasibility of the method. METHODOLOGY Multiple components of Qishen Yiqi dripping pills (QSYQ) were assayed using the high-performance liquid chromatography (HPLC)-CAD-QAMS approach. Some factors that affect the sensitivity and accuracy of the approach were sufficiently studied. After the method verification, principal component analysis (PCA) was applied to evaluate the quality consistency of three types of samples: normal samples, expired samples and negative samples. RESULTS A HPLC-CAD-QAMS method was successfully developed for the multi-component determination of QSYQ. First, chromatographic conditions were optimised by a definitive screening design, and the optimised ranges of operating parameters were obtained with a Monte Carlo simulation method. Next, a new method to select the internal reference standards was successfully introduced based on the heatmap of Pearson correlation coefficients of the response factors. Then, the multi-point method was selected to calculate the relative correction factors, and a robustness test was conducted with Plackett-Burman design. Finally, the PCA was proved to be effective for the quality consistency evaluation of different samples. CONCLUSION The developed HPLC-CAD-QAMS method can be a reliable and superior means for the multi-component quantitative analysis of QSYQ.
Collapse
Affiliation(s)
- Linlin Wu
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - Shunnan Zhang
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
- National and Local United Engineering Laboratory of TCM Advanced Manufacturing Technology, Tasly Pharmaceutical Group Co., Ltd, Tianjin, China
| | - Lihong Zhou
- National and Local United Engineering Laboratory of TCM Advanced Manufacturing Technology, Tasly Pharmaceutical Group Co., Ltd, Tianjin, China
| | - Haoshu Xiong
- National and Local United Engineering Laboratory of TCM Advanced Manufacturing Technology, Tasly Pharmaceutical Group Co., Ltd, Tianjin, China
| | - Xingchu Gong
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - Sijie Zhang
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - Jianyang Pan
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - Haibin Qu
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| |
Collapse
|